EP1399538A4 - Mise au point de voies de sialylation intracellulaires - Google Patents

Mise au point de voies de sialylation intracellulaires

Info

Publication number
EP1399538A4
EP1399538A4 EP00913684A EP00913684A EP1399538A4 EP 1399538 A4 EP1399538 A4 EP 1399538A4 EP 00913684 A EP00913684 A EP 00913684A EP 00913684 A EP00913684 A EP 00913684A EP 1399538 A4 EP1399538 A4 EP 1399538A4
Authority
EP
European Patent Office
Prior art keywords
methods
interest
cells
carbohydrate
pathways
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00913684A
Other languages
German (de)
English (en)
Other versions
EP1399538A2 (fr
Inventor
Michael J Betenbaugh
Shawn Lawrence
Yuan C Lee
Don Jarvis
Timothy A Coleman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Johns Hopkins University
University of Wyoming
Original Assignee
Human Genome Sciences Inc
Johns Hopkins University
University of Wyoming
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, Johns Hopkins University, University of Wyoming filed Critical Human Genome Sciences Inc
Publication of EP1399538A2 publication Critical patent/EP1399538A2/fr
Publication of EP1399538A4 publication Critical patent/EP1399538A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01052—Beta-N-acetylhexosaminidase (3.2.1.52)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne des méthodes de manipulation des voies de traitement des glucides dans des cellules étudiées. Ces méthodes consistent à manipuler plusieurs voies impliquées dans la réaction de sialylation par utilisation des techniques de l'ADN de recombinaison et de l'alimentation en substrat, de manière à permettre la production des glycoprotéines sialylées dans les cellules étudiées. Parmi ces travaux de manipulation réalisés sur les glucides, figurent la mise en oeuvre de nouveaux dosages biologiques, l'examen d'une sélection de lignées cellulaires d'insectes et l'utilisation de la bioinformatique pour l'identification de séquences géniques destinées au traitement critique des enzymes. L'invention concerne également des compositions renfermant les cellules étudiées produisant des glycoprotéines sialylées. Ces méthodes et ces compositions sont utilisées pour l'expression hétérologue des glycoprotéines.
EP00913684A 1999-03-02 2000-03-01 Mise au point de voies de sialylation intracellulaires Withdrawn EP1399538A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12258299P 1999-03-02 1999-03-02
US122582P 1999-03-02
US16962499P 1999-12-08 1999-12-08
US169624P 1999-12-08
PCT/US2000/005313 WO2000052135A2 (fr) 1999-03-02 2000-03-01 Mise au point de voies de sialylation intracellulaires

Publications (2)

Publication Number Publication Date
EP1399538A2 EP1399538A2 (fr) 2004-03-24
EP1399538A4 true EP1399538A4 (fr) 2004-03-24

Family

ID=26820692

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00913684A Withdrawn EP1399538A4 (fr) 1999-03-02 2000-03-01 Mise au point de voies de sialylation intracellulaires

Country Status (5)

Country Link
EP (1) EP1399538A4 (fr)
JP (1) JP2003524395A (fr)
AU (1) AU3508300A (fr)
CA (1) CA2363297C (fr)
WO (1) WO2000052135A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949372B2 (en) 1999-03-02 2005-09-27 The Johns Hopkins University Engineering intracellular sialylation pathways
AU2001236739A1 (en) * 2000-02-08 2001-08-20 Genentech Inc. Improved sialylation of glycoproteins
US7863020B2 (en) * 2000-06-28 2011-01-04 Glycofi, Inc. Production of sialylated N-glycans in lower eukaryotes
KR101495616B1 (ko) 2002-03-07 2015-02-26 아이드게노쉬쉐 테흐니쉐 호흐슐레 쥬리히 원핵 숙주에서의 재조합 글리코실화 단백질 생산 방법 및 생산계
IL163806A0 (en) * 2002-03-07 2005-12-18 Eidgenoess Tech Hochschule System and method for the production of recombinant glycosylated proteins in a prokaryotic host
JP2006333701A (ja) * 2003-01-15 2006-12-14 Kazuhito Fujiyama 動物型糖鎖をもつ糖タンパク質の生産方法
CN103627670B (zh) * 2004-02-13 2016-12-21 格莱克托普有限公司 高活性糖蛋白加工条件及其有效生产方法
EP1730293A2 (fr) * 2004-03-17 2006-12-13 Glycofi, Inc. Procede de mise au point d'une voie de synthese du monophosphate de cytidine-acide sialique dans les champignons et la levure
US20090298120A1 (en) * 2004-05-04 2009-12-03 National University Of Singapore Method for expressing sialylated glycoproteins in mammalian cells and cells thereof
US7479549B2 (en) 2005-02-23 2009-01-20 Jaques John Scott T Recombinant canine thyroid stimulating hormone and methods of production and use thereof
ES2353814T3 (es) 2005-05-11 2011-03-07 Eth Zuerich Proteinas n-glicosiladas recombinantes de celulas procariotas.
DE602006015195D1 (de) * 2005-07-12 2010-08-12 Greenovation Biotech Gmbh Verbesserungen der proteinproduktion oder in zusammenhang damit
EP3539981A1 (fr) 2006-09-10 2019-09-18 Glycotope GmbH Utilisation de cellules humaines d'origine leucémique myéloïde pour l'expression d'anticorps
PL1920781T3 (pl) 2006-11-10 2015-06-30 Glycotope Gmbh Kompozycje zawierające core-1-dodatnie mikroorganizmy i ich zastosowanie w leczeniu lub profilaktyce nowotworów
CN101983070B (zh) 2008-02-20 2016-03-30 格林考瓦因有限公司 由来源于原核细胞的重组n-糖基化蛋白制备生物共轭物
NO2501406T3 (fr) 2009-11-19 2018-05-19
EP3281639B1 (fr) 2010-05-06 2020-11-11 GlaxoSmithKline Biologicals S.A. Vaccins de bioconjugué de bactéries gram positif capsulaire
EP2412815A1 (fr) * 2010-07-27 2012-02-01 Universite De Rouen N-glycosylation dans le phaeodctylum tricornutum transformé
WO2012050175A1 (fr) * 2010-10-15 2012-04-19 日本ケミカルリサーチ株式会社 Procédé de production de glycoprotéines ayant un résidu mannose comme extrémité non réductrice de la chaîne sucrée
ES2686313T3 (es) 2011-08-22 2018-10-17 Glycotope Gmbh Microorganismos que portan un antígeno tumoral
JP6652334B2 (ja) † 2014-05-31 2020-02-19 Ｊｃｒファーマ株式会社 ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地
SG11202010496WA (en) 2018-05-18 2020-12-30 Daiichi Sankyo Co Ltd Anti-muc1 antibody-drug conjugate

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GU XUEJUN ET AL: "Improvement of interferon-gamma sialylation in Chinese hamster ovary cell culture by feeding of N-acetylmannosamine", BIOTECHNOLOGY AND BIOENGINEERING, INTERSCIENCE PUBLISHERS, LONDON, GB, vol. 58, no. 6, 20 June 1998 (1998-06-20), pages 642 - 648, XP002171407, ISSN: 0006-3592 *
OGONAH O W ET AL: "ISOLATION AND CHARACTERIZATION OF AN INSECT CELL LINE ABLE TO PERFORM COMPLEX N-LINKED GLYCOSYLATION ON RECOMBINANT PROTEINS", BIOTECHNOLOGY, BUTTERWORTHS, LONDON, GB, vol. 14, February 1996 (1996-02-01), pages 197 - 202, XP000961423, ISSN: 0740-7378 *
See also references of WO0052135A3 *

Also Published As

Publication number Publication date
WO2000052135A3 (fr) 2004-01-08
CA2363297A1 (fr) 2000-09-08
AU3508300A (en) 2000-09-21
EP1399538A2 (fr) 2004-03-24
WO2000052135A9 (fr) 2001-10-11
WO2000052135A2 (fr) 2000-09-08
JP2003524395A (ja) 2003-08-19
CA2363297C (fr) 2011-08-09

Similar Documents

Publication Publication Date Title
EP1399538A4 (fr) Mise au point de voies de sialylation intracellulaires
WO2006107990A3 (fr) Amelioration de la n-glycosylation de proteines de cellules eucaryotiques par une voie de synthese de l'oligosaccharide lie au dolichol, autres procedes d'augmentation de la n-glycosylation et produits d'expression d'hotes manipules a n-glycosylation accrue
Rautengarten et al. The elaborate route for UDP-arabinose delivery into the Golgi of plants
DE602004024649D1 (de) Produktion modifizierter glykoproteine mit mehrfach verzweigten strukturen
AU2003210405A1 (en) Inbred embryonic stem-cell derived mice
MXPA04006357A (es) Metodos para disenar estructuras de carbohidrato del tipo de mamifero.
ES2255281T3 (es) Sobreexpresion de genes de fitasa en sistmas de levadura.
MX2010002990A (es) Produccion de isoprenoides.
AUPQ422399A0 (en) Method of screening transformed or transfected cells
CN107435051A (zh) 一种通过CRISPR/Cas9系统快速获得大片段缺失的细胞系基因敲除方法
ES2096084T3 (es) Metodo para determinar la presencia de anticuerpos asociados con la diabetes o de anticuerpos dirigidos a celulas de los islotes.
AR053947A1 (es) Celulas huespedes recombinantes y medios para la produccion de etanol
SG2013021217A (en) Production of high mannose proteins in plant culture
MY146612A (en) Production of isoprenoids
WO2004074426A3 (fr) Procede et dispositifs permettant de deplacer une sonde sans lesion a travers une matiere cellulaire biologique
WO2005040377A3 (fr) Transfert et expression genique a efficacite elevee dans des cellules de mammiferes au moyen d'une procedure de transfection multiple de sequences mar
BR0008772B1 (pt) vetor de expressão, célula bacteriana ou fúngica cultivada, processos para expandir in vitro células hematopoiéticas e progenitores de células hematopoiéticas, e para detectar a presença de rna de ligando zalfa11 e de ligando zalfa 11 in vitro em uma amostra biológica.
WO2006096989A3 (fr) Vecteurs d'expression pour l'expression genetique transitoire et cellules mammaliennes les exprimant
NZ580197A (en) Substrate-selective co-fermentation process
BR9811014A (pt) "região concentrada reguladora de gene especìfica para semente precoce"
MXPA03011874A (es) Expresion genica en plastidas basadas en vectores replicantes.
EP1452595A4 (fr) Cellules es a effet arni accru
WO2006096050A3 (fr) Glyco-ingenierie de champignons
WO2002072871A3 (fr) Procede destine a l'association de voies genomiques et proteomiques associees a des processus physiologiques ou pathophysiologiques
BR0213259A (pt) Método para produzir um composto bioativo apresentando uma bioatividade conhecida, e, células recombinantes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011001

A4 Supplementary search report drawn up and despatched

Effective date: 20020827

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20080717

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090128